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Background: Chronic obstructive pulmonary disease (COPD) follows a slowly progressive
natural course that can be accelerated by acute exacerbations, which frequently trigger
admissions to hospital. Speciﬁc healthcare professional proﬁles such as that of discharge
coordinator have been successful in reducing numbers of hospitalizations and need for
medical care in patients with various chronic diseases, but data for COPD are sparse and
inconclusive. This study was conceived to test whether coordinated discharge and post-
discharge care could reduce re-hospitalizations and use of resources in patients with COPD.
Methods/Design: This ongoing single-center randomized controlled clinical trial, which
began in November 2009, is enrolling COPD patients in Global Initiative for Chronic
Obstructive Lung Disease (GOLD) stages II–IV, hospitalized because of acute exacerbation.
Patients are randomized in a 1:1 fashion to the intervention group, which has care
organized by a discharge coordinator, and a control group receiving the usual care. The
primary endpoint of the study is the number of patients hospitalized because of worsening
of COPD. Data are collected at baseline, at the time of hospital discharge, and at the
following time-points after discharge: 48 hours, 7–10 days, 30 days, 90 days, and 180 days.
Discussion: In COPD patients requiring hospital admission, coordinated discharge appears
a feasible option for improving patient and healthcare system-related outcomes. This
study will provide evidence on the effectiveness of a discharge coordinator in patients
hospitalized because of acute exacerbation of COPD and may give relevant guidance for
implementation in clinical practice.
Clinical trial registration number: NCT01225627
© 2011 Elsevier Ltd. All rights reserved.
Background
Chronic diseases are the leading cause of morbidity and
mortality in Europe, and research suggests that they will
impose an even larger burden in the future.1 Among such
diseases, chronic obstructive pulmonary disease (COPD)
contributes signiﬁcantly to disability and high death rates in
the adult population and should therefore represent a major
public health concern.2 In addition to the considerable
health burden, COPD also incurs substantial social and
economic costs.3
COPD follows a slowly progressive natural course that can
be accelerated by acute exacerbations, which frequently
trigger admissions to hospital.4 This sets the stage
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for a downward spiral where patients are experiencing
breakdowns in care during multiple transitions from hospital
to home. Such a patient journey also impairs the already
reduced health-related quality of life and translates to
about 1% of available healthcare resources.5,6 Effective
management strategies to prevent patient deterioration
are therefore essential and represent one of the key
areas of research. With lack of any clear survival beneﬁt,
pharmacological interventions primarily serve to control
symptoms and only a modest additional beneﬁt from ongoing
or planned studies is expected in future years.2
Non-pharmacological interventions focusing on tailored
care and management are much less investigated, despite
that they are likely to have considerable potential in
patients with COPD. To date, various strategies and
interventions for managing acute exacerbation of COPD
have been studied. Exacerbation prevention programs and
immediate (hospital at home) or early/assisted hospital
discharge schemes are applicable to patients with stable
disease or with mild-to-moderate worsening of COPD and
have shown reduction of healthcare utilization.7–9 Patients
with more severe deterioration have considerably increased
demand for care during hospitalization and at discharge.7
When in hospital, patients may be more receptive to non-
pharmacological interventions, and ample opportunity exists
for inclusion of patients and caregivers in management
planning and implementation. Speciﬁc healthcare profes-
sional proﬁles such as that of discharge coordinator have
been successful in reducing re-hospitalizations and need for
medical care in other chronic diseases.10–12
In COPD, the information on coordinated discharge
appears positive,13,14 but the intensity, design and setting of
the intervention to obtain maximum clinical beneﬁt is not
clearly deﬁned. This study was conceived to test whether
coordinated discharge and post-discharge care could reduce




This is an ongoing single-center randomized controlled
clinical trial to assess the effectiveness of discharge-
coordinator intervention in comparison with usual care in
patients with COPD. Figure 1 summarizes the study design.
Study participants and setting
The study, which began in November 2009, is being
conducted at the University Clinic of Pulmonary and Allergic
Diseases Golnik, Slovenia. Patients with suspected acute
exacerbation of COPD are screened on admission and
informed about the details of the study. After explanation
of any concerns and questions that they might have, signed
informed consent is collected from each patient. During
the ﬁrst 48 hours after admission, patients are enrolled
according to their eligibility (Table 1), the main inclusion
criteria being COPD stages II–IV according to the Global
Initiative for Chronic Obstructive Lung Disease (GOLD)
guidelines,15 the ability to deal with telephone contact,
and availability for home visits. Patients are excluded if
in unstable or terminal stages of disease other than COPD,
Signed informed consent
Screening and baseline assessment
Hospitalized COPD patients in GOLD stage II -IV
Acute exacerbation





-During hospitalization as needed
-After discharge: 48 hours, days 7-10
Data collection
Hospitalization: baseline, discharge
After discharge: 48 hours, days 7-10, 30, 90, 180
Primary endpoint
Hospitalization due to COPD worsening
Control group
Usual care
Fig. 1. Study ﬂow-chart.
if they die during hospitalization, or if they are unable to
follow the study protocol.
Randomization of patients, using Random Allocation
Software Version 1.0, 2004, was performed by a person
unrelated to the study. Study personnel have been given
consecutively numbered sealed envelopes and patients are
assigned to intervention or the control group according to
their sequence of entrance.
Intervention
In the intervention group, a discharge coordinator contacts
hospitalized patients the day after allocation to the group.
During hospitalization, visits by a discharge coordinator are
scheduled according to patients’ problems and homecare
needs. At 48 hours after hospital discharge, a discharge
coordinator contacts the patient by phone to check the
process of adjustment to the home environment and to
inquire about any additional needs. Thereafter, phone
contacts are scheduled according to the patients’ needs, and
7–10 days after hospital discharge a discharge coordinator
makes a home visit.
The activities of the discharge coordinator are discussed
with the attending physician and nurse as appropriate and
have the following objectives:
(1) to ensure patient education about COPD and self-care in
order that the patient has sufﬁcient knowledge and skill
to manage their disease,
(2) to include the patient’s relatives and caregivers in the
education and disease management process,
(3) to communicate the discharge planning with the patient
in order to stimulate active participation of the patient
and their relatives/caregivers,
(4) to assess the patient’s home-care needs for effective
self-care when back in the home environment,
(5) to make contact with the community care/home-
care nurse, general practitioner, social care worker,
physiotherapist, and other providers of home services
as appropriate, and
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Table 1
Summary of key inclusion and exclusion criteria
Key inclusion criteria Key exclusion criteria
Age >35 years Diagnosis of cognitive impairment
Acute exacerbation of COPD stage II–IV Unstable or terminal disease other than COPD
Residence in the geographical area linked to the study hospital Withdrawal of written informed consent before discharge
Ability to communicate by phone Inability to deal with phone contact
Written informed consent given Death during hospitalization
COPD: Chronic obstructive pulmonary disease.
(6) to provide continuity of care and care coordination
across different levels of healthcare.
Patients in the control group have their disease managed
by the attending physician, primary care physician, and/or
pneumologist in accordance with established clinical prac-
tice. In both groups, patients are followed for 180 days.
Data collection and study variables
Data are collected at baseline, at the time of hospital
discharge, and then at 48 hours, 7–10 days, 30 days,
90 days, and 180 days after hospital discharge. Patients are
contacted by phone at 48 hours, 30 days, and 90 days, and
are visited at home at 7–10 days and 180 days after hospital
discharge.
Healthcare utilization and healthcare costs
Healthcare utilization is assessed at 7–10 days, 30 days,
90 days, and 180 days after hospital discharge. Patients
and/or their caregivers are asked about all contacts
with the healthcare system. The information obtained is
veriﬁed against medical documentation. Ambulatory visits
at primary and secondary level are screened for acute
exacerbations of COPD. Hospital records are screened for
ambulatory visits and hospitalizations.
Healthcare costs per patient in the two groups will be
estimated using the current rates for healthcare utilization
as provided by the insurance companies.
Mortality
Mortality is assessed at 7–10 days, 30 days, 90 days, and
180 days after hospital discharge. If study personnel fail
to contact a patient at a scheduled time-point, relatives
and/or caregivers are asked about the vital status. Mortality
data are veriﬁed with the Central Population Registry.
Health-related quality of life
Health-related quality of life is assessed using a standard-
ized self-completed questionnaire (St. George’s Respiratory
Questionnaire) for measuring impaired health and perceived
well-being in patients with mild-to-severe airway obstruc-
tion disease.16 Data are collected at 7–10 days, 30 days,
90 days, and 180 days after hospital discharge.
Dyspnea
Patients’ level of dyspnea is assessed at the time of hospital
discharge, and at 48 hours, 7–10 days, 30 days, 90 days,
and 180 days after hospital discharge, using the modiﬁed
Medical Research Council dyspnea scale. This is a simple,
standardized, self-administered 5-point scale that quantiﬁes
the effect of breathlessness on daily activities and thus
measures perceived respiratory disability.17
Care dependency level
The level of dependency of patients is assessed at 48 hours
after hospital discharge using the Care Dependency Scale,
which can be used as a tool for case-ﬁnding and assessment
of needs in the ﬁrst stage of the nursing process. The scale
indicates the level of care needed to help the patient regain
some of their self-care abilities.18
Depression
For assessment of the presence and degree of depressive
symptomatology, the Center for Epidemiologic Studies
Depression Scale is used at 7–10 days and 180 days after
hospital discharge. This instrument is a freely available
and widely used 20-item self-report scale with emphasis on
assessment of depressed mood during the previous week.19
Sociodemographic characteristics
Data are collected at baseline using a questionnaire
developed speciﬁcally for the purpose of this study. We
collect information on age, sex, educational level, marital
status, job situation, and living conditions.
Clinical characteristics, investigations and measurements
Medical records are reviewed for information on COPD onset
and severity, smoking status, body weight, height, waist
circumference, and concomitant illness. Body mass index is
calculated (body weight in kg/square of body height in m).
During hospitalization patients undergo blood pressure
measurement, chest X-ray, pulmonary function testing,
electrocardiogram, echocardiography, body composition
assessment with bioimpedance, and exercise capacity
testing.
For laboratory investigations, blood is collected on
admission, at hospital discharge, and at 7–10 days and
180 days after discharge.
Pharmacological treatment, including exact dosing and
application, is obtained from medical records and at all
contacts with the patient.
Study endpoints
The primary endpoint of the study is the number of patients
hospitalized because of worsening of COPD. Hospitalization
is deﬁned as an unplanned overnight stay in hospital (dif-
ferent dates for admission and discharge) because of acute
worsening of COPD. Key secondary endpoints are the time to
hospitalization due to COPD worsening, all-cause mortality,
acute exacerbations of COPD, days alive and out of hospital,
health-related quality of life, and healthcare costs.
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Endpoints are assessed at regular study contacts by a study
nurse blinded to patient allocation. In addition, endpoints
are determined from review of medical records in the
electronic database, by contacting the patients and/or their




A review of the literature has shown a 40% short-term
hospitalization rate in patients admitted because of COPD
exacerbation.20 We assume that our study intervention will
reduce the hospitalization rate by 15%, thus 306 patients
would be required for detection of a difference between the
groups at a two-sided signiﬁcance level of 0.05 and with 80%
power. However, if a 20% follow-up loss rate is expected, the
necessary sample size is 184 patients per group or a total
of 368 patients. Hospital statistics at the University Clinic
of Respiratory and Allergic Diseases Golnik indicate that we
expect to enroll four patients per week.
Statistical analysis
The primary endpoint will be analyzed according to study
group allocation using the intention-to-treat principle,
and ignoring potential interventions in the control group
during follow-up. Time-to-event data will be analyzed using
Kaplan–Meier plots, and log-rank tests will be used to
compare different management strategies. A Cox model of
proportional hazards will be built for a multivariate analysis.
Results will be presented as hazard ratios with corresponding
95% conﬁdence intervals.
Descriptive statistics will include median values with
interquartile range, mean value ± standard deviation,
and absolute numbers and proportions as appropriate. To
evaluate the differences between variables, the Student’s
t-test, chi-squared test, Mann–Whitney U-test, and paired
t-test will be used. For the multivariate analysis, linear
and logistic regression models will be built. Results will be
presented as odds ratios and 95% conﬁdence intervals.
The software package SPSS 17.0 (Statistical Package for
Social Sciences Inc., Chicago, IL, USA) will be used for data
collection and all calculations. For all tests, a p-value 0.05
(two-sided) will be considered statistically signiﬁcant.
Ethical considerations
Participation in the study is voluntary and conﬁdentiality of
the study participants will be protected. Written informed
consent will be provided by all patients prior to any study-
related procedures. The study protocol was approved by
the National Medical Ethics Committee of the Republic of
Slovenia in 2009.
Current status of the study
Enrollment of patients began in November 2009. As of
January 2011, 203 patients have been enrolled. The
estimated date for study completion is November 2011.
Discussion
Studies on disease management in COPD are rare and
there is no gold standard for discharge coordination and
management in the outpatient setting. Further, patient
populations, the type and duration of intervention, and the
settings have been importantly different between studies,
thus no general advice for clinical practice can be given.
As a consequence of the lack of evidence, the GOLD
guidelines15 are nonspeciﬁc and additional research in the
ﬁeld is urgently needed.21
Chronic diseases can rarely be cured and at present our
goal remains the optimal control and stability of disease.
COPD shares typical features with other diseases of its
kind. Patients are frequently older, with several concomitant
illnesses, in need of social and medical care, and with insuf-
ﬁcient social support.1 In such a frail population, COPD has
a signiﬁcant impact on a patient’s health-related quality of
life and outcome. Deterioration caused by acute exacerba-
tion is the most common respiratory condition dealt with in
emergency departments and often requires hospital admis-
sion.9 Many episodes could be prevented provided that pa-
tients were capable of managing the disease within the lim-
its of their performance and ability. Most COPD patients have
considerable potential to improve their knowledge, skills,
and self-care management strategies. As in other chronic
conditions,22,23 assessment of a patient’s situation and
inclusion of the patient in the decision-making process can
decrease the burden of morbidity and improve outcome.
Exposure to the healthcare system, particularly hospital-
ization, drives the increasing cost of COPD management.
Several strategies focusing on tailored care have been tested
in COPD exacerbations. These include an exacerbation
prevention program and immediate or early/assisted
hospital discharge schemes,7–9 although the latter are
applicable only to patients with less severe deterioration.
It is well accepted that patients with the highest demands
and highest risk of repeated hospitalization are those with
advanced disease and those in need of hospital care. Such
patients would also beneﬁt most from speciﬁc interventions
but evidence from properly designed and conducted trials is
sparse and inconclusive.13,14
Transitional care has been deﬁned as a set of actions
designed to ensure the coordination and continuity of
healthcare as patients transfer between different locations
or different levels of care in the same location.24 Potential
solutions for improving the quality of transitional care
must be found. In patients requiring hospital admission,
coordinated discharge appears a feasible option for
improving patient and healthcare system-related outcomes.
The discharge process is a key element in the healthcare
continuum. Discharge coordination and support for COPD
patients is an important issue in minimizing the impact of
the acute episode and preventing future relapses.25 During
hospitalization, a thorough evaluation of the patient’s
knowledge of the disease and ability to perform self-care
activities, together with inclusion of caregivers, should
be mandatory. Importantly, when experiencing potentially
life threatening situations, uncontrolled dyspnea, and
reduced physical performance, patients may be more
receptive to management planning and active involvement.
Patients should be educated about skills and measures
to increase their conﬁdence about decision making once
COPD deterioration is anticipated or even present. The
discharge coordinator has sufﬁcient time and resources
to make the transition from hospital to home easier and
more patient-friendly. This provides a unique opportunity to
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coordinate between secondary and primary care, involving
other services to make disease management for patients
and/or caregivers easier and feasible.
The signiﬁcant potential for improving COPD management
through coordinated discharge in patients admitted with
COPD exacerbation is based on experience with other
diseases.10–12,22 To determine the modality, extent, intensity,
and applicability to COPD clinical practice, appropriate
studies are necessary. Interest in the ﬁeld has been
stimulated by previous and ongoing research, and the results
of our own and other ongoing trials26,27 should provide
relevant guidance for implementation in clinical practice.
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